跳至主要内容
临床试验/NCT03944330
NCT03944330Unknown不适用

A Clinic Trail on Nutrition Support Therapy of Patients With Liver Failure

Tongji Hospital0 个研究点目标入组 100 人开始时间: 2019年5月10日最近更新:
适应症

试验速览

阶段
不适用
入组人数
100
主要终点
Mortality at 30 day

研究概览

简要总结

This study is a Clinical trial to assess the efficacy of nutrition support therapy of patients with liver failure. Patients were randomized to one of 2 groups to receive different nutrition and energy support treatment.

详细描述

Patients with liver failure (defined by APASL) induced by any precipitating factors were randomized to two groups; a treatment group and a control group. Participants in treatment group were provided with a standard hospital diet that provided 25-30 kcal/kg/day . Patients in control group receive diet guide

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Male and female patients from 18 to 65 years of age;
  • Patient inclusion criteria: jaundice (serum total bilirubin ≥5 mg/dl) and coagulopathy (INR ≥ 1.5 or prothrombin activity ≥ 40 %), accompanied by ascites and/or encephalopathy within 4 weeks.

排除标准

  • Surgery with in 4 weeks
  • three degree hepatoencephalopathy
  • malignant tumors
  • cardiac failure or respiratory failure
  • liver transplantation within observing period -

结局指标

主要结局

Mortality at 30 day

时间窗: 4 weeks

The percentage of death of liver failure patients at 4 weeks

次要结局

  • Laboratory variables on serum biochemistry markers(3month)
  • Laboratory variables on fasting blood sugar(3month)
  • liver transplant-free survival(3month)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Qin Ning

Director and Chair of Department of Infectious Diseases

Tongji Hospital

相似试验